Oscar Noboa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Oscar Noboa has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- José Boggia
Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.).
10 shared publications - Leonella Luzardo
Unidad Académica de Nefrología, Hospital de Clínicas Dr. Manuel Quintela, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
10 shared publications - Jan A. Staessen
Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
7 shared publications Alicia Olascoaga
Laboratorio de Patología Clínica, Universidad de la República, Montevideo, Uruguay
5 shared publicationsLutgarde Thijs
5 shared publicationsRicardo Silvariño
Centro de Nefrología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
5 shared publications
Latest Publications
- 21 September 2026
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 42
Guía de diagnóstico y tratamiento de la microangiopatía trombótica con compromiso renal
- 21 September 2026
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 42
Guía de diagnóstico y tratamiento de la microangiopatía trombótica con compromiso renal
- 11 February 2026
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 92 (7) , 2109-2126
Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies
Aim: To guide the efficient implementation of Model‐Informed Precision Dosing (MIPD) by comparing the predictive performance of published tacrolimus population pharmacokinetic (popPK) models with an in‐house model in Uruguayan kidney transplant recipients, using comprehensive external evaluation methodology. Methods: Twenty‐five adult tacrolimus popPK models were identified through systematic review and externally evaluated using retrospective data from 39 patients (396 steady‐state concentrations). In parallel, an in‐house model was developed with prospective and retrospective data from 49 patients (727 concentrations). Predictive performance was assessed across different data integration levels: a priori predictions and sequential Bayesian forecasting with progressive incorporation of individual observations. Results: All published models and the in‐house model showed poor a priori predictive performance, with even the best performing models yielding MAPE values near 50% and fewer than 30% of predictions within 30% of observed concentrations. Bayesian forecasting progressively improved bias, accuracy and dispersion of prediction errors. Initial incorporation of three trough concentrations produced limited benefit, but substantial improvements were observed upon integration of a pharmacokinetic curve composed of at least 3 post‐dose concentrations, at which point several published models and the in‐house model achieved high precision, with mean bias below 10% and MAPE below 30%. Two published models exhibited comparable performance to the in‐house model, which achieved marginally better results as Bayesian forecasting incorporated successive individual observations, without providing a meaningful overall advantage. Conclusion: Published tacrolimus popPK models can achieve clinically reliable predictions when combined with Bayesian updating, performing comparably to in‐house developed models. These findings support a resource‐efficient strategy for implementing tacrolimus MIPD without the need for local model development, provided that a pharmacokinetic curve is obtained early post‐transplantation.
- 11 February 2026
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 92 (7) , 2109-2126
Accelerating tacrolimus model‐informed precision dosing in kidney transplant recipients: Model evaluation and refinement strategies
Aim: To guide the efficient implementation of Model‐Informed Precision Dosing (MIPD) by comparing the predictive performance of published tacrolimus population pharmacokinetic (popPK) models with an in‐house model in Uruguayan kidney transplant recipients, using comprehensive external evaluation methodology. Methods: Twenty‐five adult tacrolimus popPK models were identified through systematic review and externally evaluated using retrospective data from 39 patients (396 steady‐state concentrations). In parallel, an in‐house model was developed with prospective and retrospective data from 49 patients (727 concentrations). Predictive performance was assessed across different data integration levels: a priori predictions and sequential Bayesian forecasting with progressive incorporation of individual observations. Results: All published models and the in‐house model showed poor a priori predictive performance, with even the best performing models yielding MAPE values near 50% and fewer than 30% of predictions within 30% of observed concentrations. Bayesian forecasting progressively improved bias, accuracy and dispersion of prediction errors. Initial incorporation of three trough concentrations produced limited benefit, but substantial improvements were observed upon integration of a pharmacokinetic curve composed of at least 3 post‐dose concentrations, at which point several published models and the in‐house model achieved high precision, with mean bias below 10% and MAPE below 30%. Two published models exhibited comparable performance to the in‐house model, which achieved marginally better results as Bayesian forecasting incorporated successive individual observations, without providing a meaningful overall advantage. Conclusion: Published tacrolimus popPK models can achieve clinically reliable predictions when combined with Bayesian updating, performing comparably to in‐house developed models. These findings support a resource‐efficient strategy for implementing tacrolimus MIPD without the need for local model development, provided that a pharmacokinetic curve is obtained early post‐transplantation.
- Open Access
- 18 January 2025
- Published by Asociacion Colombiana de Nefrologia e Hipertension Arterial in Revista Colombiana de Nefrología
- Vol. 12 (1)
Hallazgos histopatológicos en riñones nativos de pacientes con diabetes mellitus tipo 2
Contexto: la alta frecuencia de diabetes mellitus (DM) hace que los pacientes con esta enfermedad puedan tener otras nefropatías. Objetivo: describir la prevalencia y las lesiones histopatológicas en biopsias renales (BR) de pacientes con DM de más de un año de diagnóstico. Metodología: se incluyó a personas con DM seguidas en el programa de salud renal, entre los años 1985-2020, con BR en ese periodo (edad ?15 años, DM ?1 año antes de BR). Resultados: se analizaron 190 BR, de pacientes con DM de 8 (1-24) años de evolución, donde el 2,63?% tuvo retinopatía. El número de BR en personas con DM fue creciente en el tiempo en Uruguay. La indicación de realizar BR fue debido a alteraciones urinarias asintomáticas (AUA) (39?%), síndrome nefrótico (SN) (28,4?%), insuficiencia renal rápidamente progresiva (11,6?%) y enfermedad renal crónica (ERC) (11?%). Además, el 11?% tuvo un patrón de nefropatía diabética (ND) y los patrones principales de nefropatía no-diabética (NND) (89?%) fueron: esclerohialinosis segmentaria y focal (EHSF) (22,63?%), nefropatía membranosa (14,21?%), vasculitis (12,63?%) e IgA (7,36?%). Los pacientes con ND se presentaron con SN (52,4?%) y AUA (19?%). Aquellos con NND y SN tenían EHSF (27,3?%) y nefropatía membranosa (23,6?%), aquellos con AUA tenían EHSF (24,1?%), vasculitis (13,9?%) e IgA (13,9?%) y aquellos con ERC tenían EHSF (20?%) y nefroangioesclerosis (16?%). La distribución de patrones lesionales del grupo con NND fue similar a la población general sin DM. Conclusiones: La BR se indica con frecuencia creciente en pacientes diabéticos, las principales indicaciones en nuestra serie fueron SN y AUA. Un bajo porcentaje tuvo solo lesiones de ND y la distribución de lesiones en pacientes con NND fue similar a la de la población adulta sin DM.
- 18 January 2025
- Published by Asociacion Colombiana de Nefrologia e Hipertension Arterial in Revista Colombiana de Nefrología
- Vol. 12 (1)
Open AccessHallazgos histopatológicos en riñones nativos de pacientes con diabetes mellitus tipo 2
Contexto: la alta frecuencia de diabetes mellitus (DM) hace que los pacientes con esta enfermedad puedan tener otras nefropatías. Objetivo: describir la prevalencia y las lesiones histopatológicas en biopsias renales (BR) de pacientes con DM de más de un año de diagnóstico. Metodología: se incluyó a personas con DM seguidas en el programa de salud renal, entre los años 1985-2020, con BR en ese periodo (edad ?15 años, DM ?1 año antes de BR). Resultados: se analizaron 190 BR, de pacientes con DM de 8 (1-24) años de evolución, donde el 2,63?% tuvo retinopatía. El número de BR en personas con DM fue creciente en el tiempo en Uruguay. La indicación de realizar BR fue debido a alteraciones urinarias asintomáticas (AUA) (39?%), síndrome nefrótico (SN) (28,4?%), insuficiencia renal rápidamente progresiva (11,6?%) y enfermedad renal crónica (ERC) (11?%). Además, el 11?% tuvo un patrón de nefropatía diabética (ND) y los patrones principales de nefropatía no-diabética (NND) (89?%) fueron: esclerohialinosis segmentaria y focal (EHSF) (22,63?%), nefropatía membranosa (14,21?%), vasculitis (12,63?%) e IgA (7,36?%). Los pacientes con ND se presentaron con SN (52,4?%) y AUA (19?%). Aquellos con NND y SN tenían EHSF (27,3?%) y nefropatía membranosa (23,6?%), aquellos con AUA tenían EHSF (24,1?%), vasculitis (13,9?%) e IgA (13,9?%) y aquellos con ERC tenían EHSF (20?%) y nefroangioesclerosis (16?%). La distribución de patrones lesionales del grupo con NND fue similar a la población general sin DM. Conclusiones: La BR se indica con frecuencia creciente en pacientes diabéticos, las principales indicaciones en nuestra serie fueron SN y AUA. Un bajo porcentaje tuvo solo lesiones de ND y la distribución de lesiones en pacientes con NND fue similar a la de la población adulta sin DM.
- Open Access
- 27 December 2021
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 15 (3) , 527-533
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant
Antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after mRNA or adenoviral vector-based vaccines is weak in kidney transplant (KT) patients. However, few studies have focused on humoral response after inactivated virus-based vaccines in KT. Here, we compare antibody response following vaccination with inactivated virus (CoronaVac®) and BNT162b2 mRNA. A national multicentre cross-sectional study was conducted. The study group was composed of patients from all KT centres in Uruguay, vaccinated between 1 and 31 May 2021 (CoronaVac®, n = 245 and BNT162b2, n = 39). The control group was constituted of 82 healthy individuals. Participants had no prior confirmed coronavirus disease 2019 (COVID-19) test. Blood samples were collected between 30 and 40 days after the second dose. Serum-specific immunoglobulin G (IgG) antibodies against the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein were determined using the COVID-19 IgG QUANT ELISA Kit. Only 29% of KT recipients showed seroconversion (36.5% BNT162b2, 27.8% inactivated virus, P = 0.248) in comparison with 100% in healthy control with either vaccine. Antibody levels against RBD were higher with BNT162b mRNA than with inactivated virus [median (interquartile range) 173 (73–554) and 29 (11–70) binding antibody units (BAU)/mL, P < 0.034] in KT and 10 times lower than healthy control [inactivated virus: 308 (209–335) and BNT162b2: 2638 (2608–3808) BAU/mL, P < 0.034]. In multivariate analysis, variables associated with negative humoral response were age, triple immunosuppression, estimated glomerular filtration rate and time post-KT. Seroconversion was low in KT patients after vaccination with both platforms. Antibody levels against SARS-CoV-2 were lower with inactivated virus than BNT162b mRNA. These findings support the need for strategies to improve immunogenicity in KT recipients after two doses of either vaccine.
- 27 December 2021
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 15 (3) , 527-533
Open AccessComparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant
Antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after mRNA or adenoviral vector-based vaccines is weak in kidney transplant (KT) patients. However, few studies have focused on humoral response after inactivated virus-based vaccines in KT. Here, we compare antibody response following vaccination with inactivated virus (CoronaVac®) and BNT162b2 mRNA. A national multicentre cross-sectional study was conducted. The study group was composed of patients from all KT centres in Uruguay, vaccinated between 1 and 31 May 2021 (CoronaVac®, n = 245 and BNT162b2, n = 39). The control group was constituted of 82 healthy individuals. Participants had no prior confirmed coronavirus disease 2019 (COVID-19) test. Blood samples were collected between 30 and 40 days after the second dose. Serum-specific immunoglobulin G (IgG) antibodies against the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein were determined using the COVID-19 IgG QUANT ELISA Kit. Only 29% of KT recipients showed seroconversion (36.5% BNT162b2, 27.8% inactivated virus, P = 0.248) in comparison with 100% in healthy control with either vaccine. Antibody levels against RBD were higher with BNT162b mRNA than with inactivated virus [median (interquartile range) 173 (73–554) and 29 (11–70) binding antibody units (BAU)/mL, P < 0.034] in KT and 10 times lower than healthy control [inactivated virus: 308 (209–335) and BNT162b2: 2638 (2608–3808) BAU/mL, P < 0.034]. In multivariate analysis, variables associated with negative humoral response were age, triple immunosuppression, estimated glomerular filtration rate and time post-KT. Seroconversion was low in KT patients after vaccination with both platforms. Antibody levels against SARS-CoV-2 were lower with inactivated virus than BNT162b mRNA. These findings support the need for strategies to improve immunogenicity in KT recipients after two doses of either vaccine.
- Open Access
Association of Dietary Patterns with Cardiovascular and Kidney Phenotypes in an Uruguayan Population Cohort
The impact of habitual diet on chronic diseases has not been extensively characterized in South America. We aimed to identify major dietary patterns (DP) in an adult cohort in Uruguay (Genotype Phenotype and Environment of Hypertension Study—GEFA-HT-UY) and to assess associations with metabolic, anthropometric characteristics, and cardiovascular and kidney phenotypes. In a cross-sectional study (n = 294), DP were derived by the principal component analysis. Blood and urine parameters, anthropometrics, blood pressure, pulse wave velocity, and glomerular filtration rate were measured. Multivariable adjusted linear models and adjusted binary logistic regression were used. Three DP were identified (Meat, Prudent, Cereal and Mate) explaining 22.6% of total variance in food intake. The traditional Meat DP, characterized by red and barbecued meat, processed meat, bread, and soft drinks, was associated with worse blood lipid profile. Prudent DP, characterized by vegetables, fish, and nuts, and lower loads for bread and crackers, was associated with reduced risk of vitamin D deficiency. Cereal and Mate DP, was characterized by higher loads of cereals, bread, and crackers, and mate infusion, with higher odds of excessive body weight. No direct associations of dietary patterns with hypertension, arterial stiffness, chronic kidney disease, and nephrolithiasis were found in the studied population, nor by age categories or sex.
Open AccessAssociation of Dietary Patterns with Cardiovascular and Kidney Phenotypes in an Uruguayan Population Cohort
The impact of habitual diet on chronic diseases has not been extensively characterized in South America. We aimed to identify major dietary patterns (DP) in an adult cohort in Uruguay (Genotype Phenotype and Environment of Hypertension Study—GEFA-HT-UY) and to assess associations with metabolic, anthropometric characteristics, and cardiovascular and kidney phenotypes. In a cross-sectional study (n = 294), DP were derived by the principal component analysis. Blood and urine parameters, anthropometrics, blood pressure, pulse wave velocity, and glomerular filtration rate were measured. Multivariable adjusted linear models and adjusted binary logistic regression were used. Three DP were identified (Meat, Prudent, Cereal and Mate) explaining 22.6% of total variance in food intake. The traditional Meat DP, characterized by red and barbecued meat, processed meat, bread, and soft drinks, was associated with worse blood lipid profile. Prudent DP, characterized by vegetables, fish, and nuts, and lower loads for bread and crackers, was associated with reduced risk of vitamin D deficiency. Cereal and Mate DP, was characterized by higher loads of cereals, bread, and crackers, and mate infusion, with higher odds of excessive body weight. No direct associations of dietary patterns with hypertension, arterial stiffness, chronic kidney disease, and nephrolithiasis were found in the studied population, nor by age categories or sex.
- 24 September 2020
- Published by Wolters Kluwer Health in Kidney360
- Vol. 1 (9) , 943-949
Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy
Background: Optimal immunosuppressive treatment for membranous nephropathy is still a matter of controversy. Current recommendations include oral cyclophosphamide combined with steroids (modified Ponticelli regimen) as first-line treatment in patients who are high risk. However, concerns about the cumulative toxicity of oral cyclophosphamide persist. In the last 30 years, a protocol based on low-dose intravenous cyclophosphamide plus steroids has been used to treat membranous nephropathy in Uruguay. We aimed to assess the efficacy of this regimen to induce clinical remission in patients with membranous nephropathy. Methods: In this retrospective, observational cohort study, we analyzed the outcome of 55 patients with membranous nephropathy treated between 1990 and 2017 with a 6-month course of alternating steroids (months 1, 3, and 5) plus intravenous cyclophosphamide (single dose of 15 mg/kg on the first day of months 2, 4, and 6). Results: At 24 months, 39 (71%) patients achieved clinical response with complete remission observed in 23 patients (42%) and partial remission in 16 (29%). Median time to achieve partial and complete remission was 5.9 and 11.5 months, respectively. Absence of response was observed in 16 patients (29%), five of whom started chronic RRT after a median follow-up of 3.5 years. Clinical relapse occurred in nine of 33 (27%) patients at a median of 34 months after treatment discontinuation. Conclusions: Replacement of oral cyclophosphamide with a single intravenous pulse on months 2, 4, and 6 of the modified Ponticelli regimen can be an effective and safe alternative for treatment of membranous nephropathy. Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/K360/2020_09_24_KID0002802020.mp3
- 24 September 2020
- Published by Wolters Kluwer Health in Kidney360
- Vol. 1 (9) , 943-949
Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy
Background: Optimal immunosuppressive treatment for membranous nephropathy is still a matter of controversy. Current recommendations include oral cyclophosphamide combined with steroids (modified Ponticelli regimen) as first-line treatment in patients who are high risk. However, concerns about the cumulative toxicity of oral cyclophosphamide persist. In the last 30 years, a protocol based on low-dose intravenous cyclophosphamide plus steroids has been used to treat membranous nephropathy in Uruguay. We aimed to assess the efficacy of this regimen to induce clinical remission in patients with membranous nephropathy. Methods: In this retrospective, observational cohort study, we analyzed the outcome of 55 patients with membranous nephropathy treated between 1990 and 2017 with a 6-month course of alternating steroids (months 1, 3, and 5) plus intravenous cyclophosphamide (single dose of 15 mg/kg on the first day of months 2, 4, and 6). Results: At 24 months, 39 (71%) patients achieved clinical response with complete remission observed in 23 patients (42%) and partial remission in 16 (29%). Median time to achieve partial and complete remission was 5.9 and 11.5 months, respectively. Absence of response was observed in 16 patients (29%), five of whom started chronic RRT after a median follow-up of 3.5 years. Clinical relapse occurred in nine of 33 (27%) patients at a median of 34 months after treatment discontinuation. Conclusions: Replacement of oral cyclophosphamide with a single intravenous pulse on months 2, 4, and 6 of the modified Ponticelli regimen can be an effective and safe alternative for treatment of membranous nephropathy. Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/K360/2020_09_24_KID0002802020.mp3
- 16 July 2019
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (8) , 1183-1192
IgA Nephropathy in Elderly Patients
Background and objectives: Some studies suggest that the incidence of IgA nephropathy is increasing in older adults, but there is a lack of information about the epidemiology and behavior of the disease in that age group. Design, setting, participants, & measurements: In this retrospective multicentric study, we analyzed the incidence, forms of presentation, clinical and histologic characteristics, treatments received, and outcomes in a cohort of 151 patients ≥65 years old with biopsy-proven IgA nephropathy diagnosed between 1990 and 2015. The main outcome was a composite end point of kidney replacement therapy or death before kidney replacement therapy. Results: We found a significant increase in the diagnosis of IgA nephropathy over time from six patients in 1990–1995 to 62 in 2011–2015 (P value for trend =0.03). After asymptomatic urinary abnormalities (84 patients; 55%), AKI was the most common form of presentation (61 patients; 40%). Within the latter, 53 (86%) patients presented with hematuria-related AKI (gross hematuria and tubular necrosis associated with erythrocyte casts as the most important lesions in kidney biopsy), and eight patients presented with crescentic IgA nephropathy. Six (4%) patients presented with nephrotic syndrome. Among hematuria-related AKI, 18 (34%) patients were receiving oral anticoagulants, and this proportion rose to 42% among the 34 patients older than 72 years old who presented with hematuria-related AKI. For the whole cohort, survival rates without the composite end point were 74%, 48%, and 26% at 1, 2, and 5 years, respectively. Age, serum creatinine at presentation, and the degree of interstitial fibrosis in kidney biopsy were risk factors significantly associated with the outcome, whereas treatment with renin-angiotensin-aldosterone blockers was associated with a lower risk. Immunosuppressive treatments were not significantly associated with the outcome. Conclusions: The diagnosis of IgA nephropathy among older adults in Spain has progressively increased in recent years, and anticoagulant therapy may be partially responsible for this trend. Prognosis was poor. Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_07_16_CJASNPodcast_19_08_.mp3
- 16 July 2019
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (8) , 1183-1192
IgA Nephropathy in Elderly Patients
Background and objectives: Some studies suggest that the incidence of IgA nephropathy is increasing in older adults, but there is a lack of information about the epidemiology and behavior of the disease in that age group. Design, setting, participants, & measurements: In this retrospective multicentric study, we analyzed the incidence, forms of presentation, clinical and histologic characteristics, treatments received, and outcomes in a cohort of 151 patients ≥65 years old with biopsy-proven IgA nephropathy diagnosed between 1990 and 2015. The main outcome was a composite end point of kidney replacement therapy or death before kidney replacement therapy. Results: We found a significant increase in the diagnosis of IgA nephropathy over time from six patients in 1990–1995 to 62 in 2011–2015 (P value for trend =0.03). After asymptomatic urinary abnormalities (84 patients; 55%), AKI was the most common form of presentation (61 patients; 40%). Within the latter, 53 (86%) patients presented with hematuria-related AKI (gross hematuria and tubular necrosis associated with erythrocyte casts as the most important lesions in kidney biopsy), and eight patients presented with crescentic IgA nephropathy. Six (4%) patients presented with nephrotic syndrome. Among hematuria-related AKI, 18 (34%) patients were receiving oral anticoagulants, and this proportion rose to 42% among the 34 patients older than 72 years old who presented with hematuria-related AKI. For the whole cohort, survival rates without the composite end point were 74%, 48%, and 26% at 1, 2, and 5 years, respectively. Age, serum creatinine at presentation, and the degree of interstitial fibrosis in kidney biopsy were risk factors significantly associated with the outcome, whereas treatment with renin-angiotensin-aldosterone blockers was associated with a lower risk. Immunosuppressive treatments were not significantly associated with the outcome. Conclusions: The diagnosis of IgA nephropathy among older adults in Spain has progressively increased in recent years, and anticoagulant therapy may be partially responsible for this trend. Prognosis was poor. Podcast: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_07_16_CJASNPodcast_19_08_.mp3
- Top Cited PapersOpen Access
- 8 May 2019
- Published by Springer Nature in Nature
- Vol. 569 (7755) , 260-264
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
Body-mass index (BMI) has increased steadily in most countries in parallel with a rise in the proportion of the population who live in cities1,2. This has led to a widely reported view that urbanization is one of the most important drivers of the global rise in obesity3–6. Here we use 2,009 population-based studies, with measurements of height and weight in more than 112 million adults, to report national, regional and global trends in mean BMI segregated by place of residence (a rural or urban area) from 1985 to 2017. We show that, contrary to the dominant paradigm, more than 55% of the global rise in mean BMI from 1985 to 2017—and more than 80% in some low- and middle-income regions—was due to increases in BMI in rural areas. This large contribution stems from the fact that, with the exception of women in sub-Saharan Africa, BMI is increasing at the same rate or faster in rural areas than in cities in low- and middle-income regions. These trends have in turn resulted in a closing—and in some countries reversal—of the gap in BMI between urban and rural areas in low- and middle-income countries, especially for women. In high-income and industrialized countries, we noted a persistently higher rural BMI, especially for women. There is an urgent need for an integrated approach to rural nutrition that enhances financial and physical access to healthy foods, to avoid replacing the rural undernutrition disadvantage in poor countries with a more general malnutrition disadvantage that entails excessive consumption of low-quality calories.
- 8 May 2019
- Published by Springer Nature in Nature
- Vol. 569 (7755) , 260-264
Top Cited PapersOpen AccessRising rural body-mass index is the main driver of the global obesity epidemic in adults
Body-mass index (BMI) has increased steadily in most countries in parallel with a rise in the proportion of the population who live in cities1,2. This has led to a widely reported view that urbanization is one of the most important drivers of the global rise in obesity3–6. Here we use 2,009 population-based studies, with measurements of height and weight in more than 112 million adults, to report national, regional and global trends in mean BMI segregated by place of residence (a rural or urban area) from 1985 to 2017. We show that, contrary to the dominant paradigm, more than 55% of the global rise in mean BMI from 1985 to 2017—and more than 80% in some low- and middle-income regions—was due to increases in BMI in rural areas. This large contribution stems from the fact that, with the exception of women in sub-Saharan Africa, BMI is increasing at the same rate or faster in rural areas than in cities in low- and middle-income regions. These trends have in turn resulted in a closing—and in some countries reversal—of the gap in BMI between urban and rural areas in low- and middle-income countries, especially for women. In high-income and industrialized countries, we noted a persistently higher rural BMI, especially for women. There is an urgent need for an integrated approach to rural nutrition that enhances financial and physical access to healthy foods, to avoid replacing the rural undernutrition disadvantage in poor countries with a more general malnutrition disadvantage that entails excessive consumption of low-quality calories.
- Open Access
- 2 December 2018
- Published by Wiley in International Journal of Hypertension
- Vol. 2018, 1-10
Blood Pressure in relation to 24-Hour Urinary Sodium and Potassium Excretion in a Uruguayan Population Sample
Many public health policies in Latin America target an optimized sodium and potassium intake. The aims of this study were to assess the sodium and potassium intake using 24-hour urinary analysis and to study their association with blood pressure in a Uruguayan population cohort using cluster analysis. A total of 149 participants (aged 20–85 years) were included in the study, and office blood pressure, anthropometric measurements, biochemical parameters in the blood, and 24-hour urine samples were obtained. The overall mean sodium and potassium excretion was 152.9 ± 57.3 mmol/day (8.9 ± 3.4 g/day of salt) and 55.4 ± 19.6 mmol/day, respectively. The average office systolic/diastolic blood pressure was 124.6 ± 16.7/79.3 ± 9.9 mmHg. Three compact spherical clusters were defined in untreated participants based on predetermined attributes, including blood pressure, age, and sodium and potassium excretion. The major characteristics of the three clusters were (1) high systolic blood pressure and moderate sodium excretion, (2) moderate systolic blood pressure and very high sodium excretion, and (3) low systolic blood pressure and low sodium excretion. Participants in cluster three had systolic blood pressure values that were 23.9 mmHg (95% confidence interval: −29.5 to −1.84) lower than those in cluster one. Participants in cluster two had blood pressure levels similar to those in cluster one (P = 0.32) and worse metabolic profiles than those in cluster one and three (P < 0.05). None of the clusters showed high blood pressure levels and high sodium excretion. No linear association was found between blood pressure and urinary sodium excretion (r < 0.14; P > 0.47). An effect of sodium and potassium intake on blood pressure levels was not found at the population level using regression or cluster analysis.
- 2 December 2018
- Published by Wiley in International Journal of Hypertension
- Vol. 2018, 1-10
Open AccessBlood Pressure in relation to 24-Hour Urinary Sodium and Potassium Excretion in a Uruguayan Population Sample
Many public health policies in Latin America target an optimized sodium and potassium intake. The aims of this study were to assess the sodium and potassium intake using 24-hour urinary analysis and to study their association with blood pressure in a Uruguayan population cohort using cluster analysis. A total of 149 participants (aged 20–85 years) were included in the study, and office blood pressure, anthropometric measurements, biochemical parameters in the blood, and 24-hour urine samples were obtained. The overall mean sodium and potassium excretion was 152.9 ± 57.3 mmol/day (8.9 ± 3.4 g/day of salt) and 55.4 ± 19.6 mmol/day, respectively. The average office systolic/diastolic blood pressure was 124.6 ± 16.7/79.3 ± 9.9 mmHg. Three compact spherical clusters were defined in untreated participants based on predetermined attributes, including blood pressure, age, and sodium and potassium excretion. The major characteristics of the three clusters were (1) high systolic blood pressure and moderate sodium excretion, (2) moderate systolic blood pressure and very high sodium excretion, and (3) low systolic blood pressure and low sodium excretion. Participants in cluster three had systolic blood pressure values that were 23.9 mmHg (95% confidence interval: −29.5 to −1.84) lower than those in cluster one. Participants in cluster two had blood pressure levels similar to those in cluster one (P = 0.32) and worse metabolic profiles than those in cluster one and three (P < 0.05). None of the clusters showed high blood pressure levels and high sodium excretion. No linear association was found between blood pressure and urinary sodium excretion (r < 0.14; P > 0.47). An effect of sodium and potassium intake on blood pressure levels was not found at the population level using regression or cluster analysis.
- Open Access
- 29 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0206637
Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014
Our aim is to describe variations in the incidence rates of glomerular disease diagnosed by renal biopsies performed in Uruguay over the last 25 years in relation to sex, age, clinical presentation and histological diagnosis. We analyzed all renal biopsies performed in Uruguay during the 25 years period and estimated incidence rates per million people per year (pmp/yr) for the population older than 14 years. Mann Kendall's trend analysis was used to assess incidence trends. In order to identify changes in trends, we compared annual incidence rates with the Joinpoint method. From 1990 to 2014, 3390 biopsies of native kidneys corresponding to glomerular disease were performed in patients older than 14 years. The average biopsy rate was 58 per pmp/yr. The glomerular disease incidence rate increased progressively over the period (p<0.05). Trends analysis over five-year periods demonstrated a progressive increase of IgA nephropathy (3.08 pmp/yr 1990–1994 to 12.53 pmp/yr 2010–2014 p<0.05), membranous nephropathy (2.38 pmp/yr 1990–1994 to 8.04 pmp/yr 2010–2014 p< 0.05) and lupus nephritis (4,23 pmp/yr 1990–1994 to 7,81 pmp/yr 2010–2014 p<0.05). There was a change in the trend of focal segmental glomerular sclerosis (FSGS) which increased until 1996 and decreased afterwards. The incidence rates of glomerular disease have doubled globally in the last quarter of a century in Uruguay, mainly related to the increase of IgA nephropathy, membranous nephropathy and lupus nephritis. There was a change in the slope of the incidence rate of FSGS.
- 29 October 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0206637
Open AccessTemporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014
Our aim is to describe variations in the incidence rates of glomerular disease diagnosed by renal biopsies performed in Uruguay over the last 25 years in relation to sex, age, clinical presentation and histological diagnosis. We analyzed all renal biopsies performed in Uruguay during the 25 years period and estimated incidence rates per million people per year (pmp/yr) for the population older than 14 years. Mann Kendall's trend analysis was used to assess incidence trends. In order to identify changes in trends, we compared annual incidence rates with the Joinpoint method. From 1990 to 2014, 3390 biopsies of native kidneys corresponding to glomerular disease were performed in patients older than 14 years. The average biopsy rate was 58 per pmp/yr. The glomerular disease incidence rate increased progressively over the period (p<0.05). Trends analysis over five-year periods demonstrated a progressive increase of IgA nephropathy (3.08 pmp/yr 1990–1994 to 12.53 pmp/yr 2010–2014 p<0.05), membranous nephropathy (2.38 pmp/yr 1990–1994 to 8.04 pmp/yr 2010–2014 p< 0.05) and lupus nephritis (4,23 pmp/yr 1990–1994 to 7,81 pmp/yr 2010–2014 p<0.05). There was a change in the trend of focal segmental glomerular sclerosis (FSGS) which increased until 1996 and decreased afterwards. The incidence rates of glomerular disease have doubled globally in the last quarter of a century in Uruguay, mainly related to the increase of IgA nephropathy, membranous nephropathy and lupus nephritis. There was a change in the slope of the incidence rate of FSGS.